BullFrog AI announced the appointment of new Chief Scientific Officer

BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of Dr. Thomas W. Chittenden, PhD, DPhil, PStat, as its new Chief Scientific Officer. With a...

The post BullFrog AI announced the appointment of new Chief Scientific Officer first appeared on AI-TechPark.

artificial artificial intelligence development drug development intelligence machine machine learning nasdaq pharmaceuticals phd technology thomas